Ipamorelin 5mg

đźš§ Coming Soon

$39.99

Ipamorelin is a selective growth hormone secretagogue (GHRP) studied for its ability to stimulate natural GH release without affecting cortisol or prolactin levels. It may support muscle recovery, fat metabolism, and anti-aging pathways in preclinical models.
⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.

Categories: ,

Description

Ipamorelin is a synthetic peptide classified as a growth hormone releasing peptide (GHRP), researched for its selective action in stimulating growth hormone (GH) secretion via ghrelin receptor activation. Unlike older GHRPs such as GHRP-6 or GHRP-2, Ipamorelin offers a more refined profile—inducing GH release without elevating cortisol, prolactin, or appetite-related hormones, making it a popular candidate in regenerative, anti-aging, and performance-related preclinical research.

Ipamorelin is often studied alone or stacked with GHRH analogs like CJC-1295 to amplify the body’s natural pulsatile GH production.

How Ipamorelin Works (Based on Preclinical Research):

  • Mimics ghrelin to bind GHSR-1a receptors and stimulate GH release

  • Does not elevate cortisol or prolactin, avoiding stress hormone spikes

  • Supports natural GH pulsatility for targeted recovery and regeneration

  • Enhances research consistency with minimal off-target endocrine activity

Potential Benefits (Based on Preclinical Research):

  • Supports lean muscle growth and fat metabolism

  • May improve recovery and repair of soft tissue and joints

  • Promotes sleep quality and cellular regeneration

  • Minimal side effects compared to earlier GHRPs


⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.

Reviews

There are no reviews yet.

Be the first to review “Ipamorelin 5mg”

Your email address will not be published. Required fields are marked *